Tuesday, November 15, 2016
- 9:00AM-11:00AM
-
Abstract Number: 2096
Venous Antiphospholipid Syndrome: Is the Unprovoked Nature of the 1st Thrombosis Associated with Clinical or Biological Features?
Antiphospholipid Syndrome - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2187
Vitamin D Levels and Fragility Fractures in Postmenopausal Portuguese Women- Results from Epireumapt
Epidemiology and Public Health - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2399
Waning Hepatitis B Immunity Status in a Significant Proportion of Immunocompromised Pediatric Rheumatology and Gastroenterology Patients
Pediatric Rheumatology – Clinical and Therapeutic Aspects - Poster III: Systemic JIA, Autoinflammatory Syndromes, Scleroderma, Vasculitis, Miscellaneous- 9:00AM-11:00AM
-
Abstract Number: 2471
What Are the Reasons of Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity and What Is the Impact of This Discordance on Remission, Function and Structure at 1 Year?
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2179
What Are the Risk Factors for Knee Pain, Radiographic Knee Osteoarthritis and Total Knee Replacement in Professional Footballers?
Epidemiology and Public Health - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2709
Which Cells Correspond to the Typical Signals for Fatty and Inflammatory Lesions Seen in Magnetic Resonance Imaging in Ankylosing Spondylitis ? -a Prospective Study Using Biopsy Material Obtained during Spinal Surgery-
Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2862
Whole Blood Phenotyping and Innate and Adaptive Stimulation Reveal Unique Differences in Granulocytes and Innate Pathways of African American SLE Patients with Variable Disease Activity
Systemic Lupus Erythematosus – Human Etiology and Pathogenesis - Poster II- 9:00AM-11:00AM
-
Abstract Number: 2667
Whole Frequency Audiometrical Correlation with Disease Activity in Primary SjöGren’s Syndrome in Hispanic Population
Sjögren's Syndrome - Poster II: Clinical Science- 9:00AM-11:00AM
-
Abstract Number: 2657
Withdrawal of Nonsteroidal Anti-Inflammatory Drugs in Rheumatoid Arthritis Patients with Low Disease Activity
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster III- 9:00AM-11:00AM
-
Abstract Number: 2119
Wogonin, a Plant-Derived Flavonoid, Exert Anti-Inflammatory and Chondroprotective Effects through the Activation Nrf2/HO-1 Signaling in Human OA Chondrocytes
Biology and Pathology of Bone and Joint - Poster I- 9:00AM-11:00AM
-
Abstract Number: 2670
Work Disability in Newly Diagnosed Patients with Primary SjöGren’s Syndrome – a Population-Based Cohort Study
Sjögren's Syndrome - Poster II: Clinical Science- 9:00AM-11:00AM
-
Abstract Number: 2479
Work Productivity in Early Rheumatoid Arthritis Patients Treated before and after Implementation of a Treat-to-Target Strategy
Rheumatoid Arthritis – Clinical Aspects - Poster III: Treatment – Monitoring, Outcomes, Adverse Events- 9:00AM-11:00AM
-
Abstract Number: 2910
Work Productivity in Systemic Sclerosis and Association with Health Related Quality of Life
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's – Clinical Aspects and Therapeutics - Poster III- 11:00AM-12:30PM
-
Abstract Number: 2987
Comparison of Certolizumab Pegol Versus Adalimumab: 2 Year Efficacy and Safety Results from a Superiority, Investigator-Blind, Head-to-Head Study